Skip to Main Content

Author Details

David B Rein
NORC at the University of Chicago
1999
75
27
PMIDPaper TitleJournal TitlePublished Year
37389780A Mixed-Methods Approach for Evaluating Implementation Processes and Program Costs for a Hypertension Management Program Implemented in a Federally Qualified Health Center.Prev Sci2024
36637915Trends in the Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Commercially Insured Adults Aged <65 Years.Diabetes Care2023
37022712Association Between Social Determinants of Health and Examination-Based Vision Loss vs Self-reported Vision Measures.JAMA Ophthalmol2023
37318810Prevalence of Diabetic Retinopathy in the US in 2021.JAMA Ophthalmol2023
37387725Effectiveness evaluation of a hypertension management program in a Federally Qualified Health Center (FQHC).Prev Med Rep2023
37140901Validity of Administrative Claims and Electronic Health Registry Data From a Single Practice for Eye Health Surveillance.JAMA Ophthalmol2023
34560128The Economic Burden of Vision Loss and Blindness in the United States.Ophthalmology2022
35797011County-Level Variation in the Prevalence of Visual Acuity Loss or Blindness in the US.JAMA Ophthalmol2022
36178388Evaluating Evidence-Informed Behavioral Health Models to Improve HIV Health Outcomes: Quantitative Findings from the Ryan White HIV/AIDS Program Special Projects of National Significance Black Men Who Have Sex with Men Initiative.AIDS Patient Care STDS2022
36326752Prevalence of Age-Related Macular Degeneration in the US in 2019.JAMA Ophthalmol2022
35240921High-Risk Injection-Related Practices Associated with anti-HCV Positivity among Young Adults Seeking Services in Three Small Cities in Wisconsin.Subst Use Misuse2022
35238912Trends in Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Medicare Part B Fee-for-Service Beneficiaries.JAMA Ophthalmol2022
32663529Vision Impairment and Blindness Prevalence in the United States: Variability of Vision Health Responses across Multiple National Surveys.Ophthalmology2021
34530688The Prevalence of Diagnosis of Major Eye Diseases and their Associated Payments in the Medicare Fee-for-Service Program.Ophthalmic Epidemiol2021
33983373Prevalence of Visual Acuity Loss or Blindness in the US: A Bayesian Meta-analysis.JAMA Ophthalmol2021
31505088Defining the hepatitis C cure cascade in an Urban health system using the electronic health record.J Viral Hepat2020
28941361Hepatitis C virus testing for case identification in persons born during 1945-1965: Results from three randomized controlled trials.Hepatology2018
30222920Hepatitis C care cascade among persons born 1945-1965: 3 medical centers.Am J Manag Care2018
29566863Establishing a Vision and Eye Health Surveillance System for the Nation: A Status Update on the Vision and Eye Health Surveillance System.Ophthalmology2018
27496859Implementation of Birth-Cohort Testing for Hepatitis C Virus.Health Promot Pract2017
28358948Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System.JAMA Ophthalmol2017
28288075An Electronic Health Record-based Intervention to Promote Hepatitis C Virus Testing Among Adults Born Between 1945 and 1965: A Cluster-randomized Trial.Med Care2017
29404448Potential epidemiologic, economic, and budgetary impacts of current rates of hepatitis C treatment in medicare and non-medicare populations.Hepatol Commun2017
28796854The Promise and Potential of Pediatric Vision Data.JAMA Ophthalmol2017
27770543Uptake of hepatitis C screening, characteristics of patients tested, and intervention costs in the BEST-C study.Hepatology2017
26707033The burden of hepatitis C to the United States Medicare system in 2009: Descriptive and economic characteristics.Hepatology2016
27394647The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.Lancet2016
27317459Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children.Vaccine2016
24776636Hepatitis C virus testing perspectives among primary care physicians in four large primary care settings.Health Promot Pract2015
26261202Reply to Messori.Clin Infect Dis2015
26091742Nepali earthquakes and the risk of an epidemic of hepatitis E.Lancet2015
25896194HIV Infection Status as a Predictor of Hepatitis C Virus RNA Testing in Primary Care.Am J Prev Med2015
25778747The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus.Clin Infect Dis2015
25595745Hepatitis C virus antibody positivity and predictors among previously undiagnosed adult primary care outpatients: cross-sectional analysis of a multisite retrospective cohort study.Clin Infect Dis2015
23511113Attributes associated with eye care use in the United States: a meta-analysis.Ophthalmology2013
24335062Vision problems are a leading source of modifiable health expenditures.Invest Ophthalmol Vis Sci2013
21877675The potential cost-effectiveness of amblyopia screening programs.J Pediatr Ophthalmol Strabismus2012
23754160The economics of the initial preventive physical examination in medicare-reply.Arch Ophthalmol2012
23245608Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.Lancet2012
23245607Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.Lancet2012
23245604Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.Lancet2012
22922026Data to guide the "test and treat era" of hepatitis C.Gastroenterology2012
22895429Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.MMWR Recomm Rep2012
22232367The cost-effectiveness of Welcome to Medicare visual acuity screening and a possible alternative welcome to medicare eye evaluation among persons without diagnosed diabetes mellitus.Arch Ophthalmol2012
22056542The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings.Ann Intern Med2012
22121109The global burden of hepatitis E virus genotypes 1 and 2 in 2005.Hepatology2012
20739252Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States.Dig Liver Dis2011
21800750Models of community-based hepatitis B surface antigen screening programs in the U.S. and their estimated outcomes and costs.Public Health Rep2011
21492158The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy.Health Serv Res2011
21076360Cost-effectiveness of glaucoma interventions in Barbados and Ghana.Optom Vis Sci2011
  • 1 - 50 of 75

Recommended Authors

Rhode Island Public Health Institute
Career Start Year 2018
Number of shared co-authors 0
University of California Los Angeles
Career Start Year 2017
Number of shared co-authors 0
Harvard T.H. Chan School of Public Health
Career Start Year 2017
Number of shared co-authors 0
Duke University Medical Center
Career Start Year 2014
Number of shared co-authors 0
Wake Forest University
Career Start Year 2013
Number of shared co-authors 0
University of California los angeles
Career Start Year 2013
Number of shared co-authors 0
Nationwide Children's Hospital Columbus
Career Start Year 2012
Number of shared co-authors 0
University of Pennsylvania Perelman School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Axtria Inc.
Career Start Year 2005
Number of shared co-authors 1
USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Career Start Year 2005
Number of shared co-authors 0
University of Pittsburgh School of Public Health
Career Start Year 2004
Number of shared co-authors 0
Jr. VA Hospital
Career Start Year 2004
Number of shared co-authors 0
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year 2004
Number of shared co-authors 0
Harvard Medical School
Career Start Year 2004
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 2002
Number of shared co-authors 0
Centers for Disease Control and Prevention
Career Start Year 2000
Number of shared co-authors 4
The Pirbright Institute
Career Start Year 2000
Number of shared co-authors 14
Centers for Disease Control and Prevention
Career Start Year 1999
Number of shared co-authors 3
Nationwide Children's Hospital
Career Start Year 1998
Number of shared co-authors 4
David Geffen School of Medicine, University of California los angeles
Career Start Year 1998
Number of shared co-authors 0
University of California san francisco
Career Start Year 1993
Number of shared co-authors 0
University of Southern California
Career Start Year 1992
Number of shared co-authors 0
Yale School of Public Health
Career Start Year 1991
Number of shared co-authors 0
Kaiser Permanente Center for Health Research, Kaiser Permanente
Career Start Year 1990
Number of shared co-authors 0
School of Public Health, University of Pittsburgh
Career Start Year 1988
Number of shared co-authors 0
Tufts University School of Medicine
Career Start Year 1986
Number of shared co-authors 0
university of california san diego
Career Start Year 1983
Number of shared co-authors 0
Centers for Disease Control and Prevention
Career Start Year 1982
Number of shared co-authors 0
Fielding School of Public Health, University of California los angeles
Career Start Year 1981
Number of shared co-authors 3
Boston University
Career Start Year 1978
Number of shared co-authors 2

Collaborators

NORC at the University of Chicago
Co-authored papers 30
US Centers for Disease Control and Prevention
Co-authored papers 19
Centers for Disease Control and Prevention
Co-authored papers 11
Institute for Health Metrics and Evaluation, University of Washington
Co-authored papers 8
Rollins School of Public Health, Emory University
Co-authored papers 5
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 4
Center for Space Medicine, Baylor College of Medicine
Co-authored papers 4
University at Buffalo Jacobs School of Medicine and Biomedical Sciences
Co-authored papers 3
and Blood Institute
Co-authored papers 3
University of Wisconsin School of Medicine and Public Health
Co-authored papers 3
University of Washington.
Co-authored papers 3
University of Washington School of Medicine
Co-authored papers 3
Co-authored papers 3
College of Medicine and Public Health, Flinders University
Co-authored papers 3
The EMMES Corporation
Co-authored papers 3
Co-authored papers 3
Peking University School of Public Health
Co-authored papers 3
The University of Melbourne
Co-authored papers 3
University of Tennessee Health Science Center
Co-authored papers 3
Yale School of Public Health
Co-authored papers 3
Boston Children's Hospital, Harvard Medical School
Co-authored papers 3
University of Washington
Co-authored papers 2
Centers for Disease Control and Prevention
Co-authored papers 2
University of New South Wales
Co-authored papers 2
Harvard University, Moorfields Eye Hospital NHS Foundation Trust, St. John's Mercy Hospital, University of British Columbia, University of Washington, Washington University in Saint Louis
Co-authored papers 2
University of Washington
Co-authored papers 2
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers 2
University of Alabama at Birmingham
Co-authored papers 2